Lots of Cash, no debt. FDA trials complete. RMTI FINALLY in the sweet spot.
It's been one ugly ride, but Key-oh-weenie (Chioini) finally seems to have turned the corner.
Unless something goes crazy bad with the CRUISE-2 trial, it looks lilke Chioini is finally in a position to bid Davita and Fresenius against each other on SFP. Frankly it would be a smart move for one of them to buy RMTI for a few hundred million.
Remember, dialysis centers get paid a FIXED PRICE for outcomes by Medicare/Medicaid. There is HUGE incentive for them to cut the cost of iron therapy. SFP is a no-brainer way to do it.
It's gonna get interesting in the next few months...............